Arrowhead Pharmaceuticals Competitors and Similar CompaniesClear all
Arrowhead Pharmaceuticals's competitors and similar companies include Ionis Pharmaceuticals, Wave Life Sciences, Vivet Therapeutics and Aktogen.
 Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals is a biopharmaceutical company that specializes in drug development. |  Ionis Pharmaceuticals Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics. |  Wave Life Sciences Wave Life Sciences is a clinical stage genetic medicine company focused on advancing stereo pure nucleic acid therapeutics that precisely target the underlying cause of rare diseases, with a goal of delivering exceptional treatment options for patients. |  Vivet Therapeutics Vivet Therapeutics is dedicated to developing innovative gene therapy treatments for orphan diseases. |  Aktogen Aktogen is a company that offers behaviour and genetic services for fruit fly, Drosophila melanogaster laboratories as well as pharmaceutical companies. | |
Founding Date | Founding Date 2001 | Founding Date 1989 | Founding Date 2012 | Founding Date 2016 | Founding Date 2003 |
Type | Type Public | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Pasadena, US HQ Madison, US San Diego, US | Locations Cambridge, US HQ Dublin 1, IE Kagoshima, JP Singapore, SG Birmingham, GB Lexington, US | Locations Paris, FR HQ | Locations Ramsey, GB HQ | |
Employees | Employees 13416% increase | Employees 1,40231% increase | Employees 23522% decrease | Employees 195% decrease | Employees 2 |
Valuation ($) | Valuation ($) 2.5 b | Valuation ($) 6.3 b | Valuation ($) 2.3 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $829.4m (FY, 2025) | Revenue (est.) $943.7m (FY, 2025) | Revenue (est.) $42.7m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income $30.1m (FY, 2025) | Net income ($381.4m) (FY, 2025) | Net income ($204.4m) (FY, 2025) | Net income N/A | Net income N/A |
Operating ⚠ | |||||
Patents Issued | Patents Issued 359 (FY, 2016) | Patents Issued N/A | Patents Issued 27 (FY, 2016) | Patents Issued N/A | Patents Issued N/A |
Phase I Trials Products | Phase I Trials Products N/A | Phase I Trials Products 1 (FY, 2023) | Phase I Trials Products 20 (FY, 2016) | Phase I Trials Products N/A | Phase I Trials Products N/A |
Phase II Trials Products | Phase II Trials Products N/A | Phase II Trials Products 18 (FY, 2024) | Phase II Trials Products 3 (FY, 2016) | Phase II Trials Products N/A | Phase II Trials Products N/A |
Funding | |||||
Total funding raised | Total funding raised $ 147.1m | Total funding raised N/A | Total funding raised $ 30m | Total funding raised $ 92.1m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Ionis Pharmaceuticals
HQ
Carlsbad, US
Employees
1,402↑ 31% increase
Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.
View companyWave Life Sciences
HQ
Cambridge, US
Employees
235↓ 22% decrease
Wave Life Sciences is a clinical stage genetic medicine company focused on advancing stereo pure nucleic acid therapeutics that precisely target the underlying cause of rare diseases, with a goal of delivering exceptional treatment options for patients.
View companyVivet Therapeutics
HQ
Paris, FR
Employees
19↓ 5% decrease
Vivet Therapeutics is dedicated to developing innovative gene therapy treatments for orphan diseases.
View companyAktogen
HQ
Ramsey, GB
Employees
2
Aktogen is a company that offers behaviour and genetic services for fruit fly, Drosophila melanogaster laboratories as well as pharmaceutical companies.
View company